PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER

被引：0
|
作者：
MATSUI, Y
OSHIMA, S
KADO, M
NAKAYAMA, M
SHIMOKATA, K
SAKAI, S
ITO, F
CHIKATA, E
HARA, K
KANDA, T
SHIMA, K
TAKENAKA, S
HOKAMA, S
GENGA, K
机构：
[1] NAGOYA 1ST RED CROSS HOSP,DEPT INTERNAL MED,NAGOYA,JAPAN
[2] NATL TONEYAMA HOSP,DEPT INTERNAL MED,TOYONAKA,JAPAN
[3] UNIV RYUKYUS,SCH MED,DEPT CENT CLIN LAB,NAHA,OKINAWA 903,JAPAN
[4] KUMAMOTO MUNICIPAL HOSP,DEPT INTERNAL MED,KUMAMOTO,JAPAN
[5] KYOTO 1ST RED CROSS HOSP,DEPT RESP DIS,KYOTO,JAPAN
[6] NATL OKINAWA HOSP,DEPT SURG,OKINAWA,JAPAN
[7] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 1,NAGOYA,AICHI 464,JAPAN
[8] NAGASAKI UNIV,SCH MED,DEPT INTERNAL MED 2,NAGASAKI 852,JAPAN
来源：
CANCER | 1987年 / 60卷 / 12期
关键词：
D O I：
10.1002/1097-0142(19871215)60:12<2882::AID-CNCR2820601205>3.0.CO;2-A
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2882 / 2885
页数：4
相关论文
共 50 条
  • [21] CIS-DICHLORODIAMMINEPLATINUM (II) AND VP-16-213 COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    GOLDHIRSCH, A
    JOSS, RA
    CAVALLI, F
    SONNTAG, RW
    BRUNNER, KW
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03): : 205 - 208
  • [22] VP-16-213 IN COMBINATION CHEMOTHERAPY WITH CHEST IRRADIATION FOR SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL OF THE PIEDMONT ONCOLOGY ASSOCIATION
    JACKSON, DV
    ZEKAN, PJ
    CALDWELL, RD
    SLATKOFF, ML
    HARDING, RW
    CASE, LD
    HOPKINS, JO
    MUSS, HB
    RICHARDS, F
    WHITE, DR
    COOPER, MR
    STUART, JJ
    CAPIZZI, RL
    SPURR, CL
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1343 - 1351
  • [23] CIS-PLATINUM AND VP-16-213 (ETOPOSIDE) COMBINATION CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG-CANCER - A PHASE-II CLINICAL-TRIAL
    KLIPPSTEIN, T
    GRAUBNER, M
    BERDEL, WE
    MENDE, S
    GROPP, C
    DIEHL, V
    MITROU, PS
    ONKOLOGIE, 1983, 6 (06): : 306 - 311
  • [24] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP-16-213) IN EXTENSIVE-STAGE SMALL CELL LUNG-CANCER
    MATELSKI, HW
    LOKICH, JJ
    HUBERMAN, MS
    ZIPOLI, TE
    PAUL, S
    SONNEBORN, H
    PHILIPS, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 729 - 732
  • [25] PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER
    WIESENFELD, A
    JETT, JR
    SU, JQ
    BRAICH, TA
    KARDINAL, CG
    MAILLIARD, JA
    VEEDER, MH
    MORTON, RF
    MICHALAK, JC
    CANCER, 1994, 73 (04) : 1189 - 1193
  • [26] PHASE-II TRIALS OF SMALL-CELL LUNG-CANCER - REPLY
    GRANT, SC
    KRIS, MG
    ORAZEM, J
    GRALLA, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) : 1370 - 1370
  • [27] PHASE-II CLINICAL-TRIAL OF VP-16-213 IN OVARIAN-CANCER
    MASKENS, AP
    ARMAND, JP
    LACAVE, AJ
    DEJAGER, RL
    HANSEN, HH
    WOLFF, JPM
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 329 - 330
  • [28] PHASE-II TRIAL OF ORAL VP-16-213 (ETOPOSIDE) IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    CRIVELLARI, D
    VERONESI, A
    MAGRI, MD
    TIRELLI, U
    COMORETTO, R
    BARZAN, L
    CARUSO, G
    CARBONE, A
    GRIGOLETTO, E
    TUMORI JOURNAL, 1985, 71 (05): : 499 - 500
  • [29] ETOPOSIDE (VP-16-213) IN MALIGNANT BRAIN-TUMORS - A PHASE-II STUDY
    TIRELLI, U
    DINCALCI, M
    CANETTA, R
    TUMOLO, S
    FRANCHIN, G
    VERONESI, A
    GALLIGIONI, E
    TROVO, MG
    ROSSI, C
    GRIGOLETTO, E
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 432 - 437
  • [30] TENIPOSIDE FOR BRAIN METASTASES OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    POSTMUS, PE
    SMIT, EF
    HAAXMAREICHE, H
    VANZANDWIJK, N
    ARDIZZONI, A
    QUOIX, E
    KIRKPATRICK, A
    SAHMOUD, T
    GIACCONE, G
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 660 - 665
12345